Traumalix forte EmGel
Traumalix forte EmGel is a medicine authorised by Swissmedic under authorisation number 66403. The authorisation holder is Drossapharm AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 12 January 2017 and the authorisation is valid without a time limit. ATC code M02AA06 places the medicine in the group Topical products for joint and muscular pain.
| Authorisation number | 66403 |
|---|---|
| Name | Traumalix forte EmGel |
| Full name | Traumalix forte EmGel, Gel |
| Authorisation holder | Drossapharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | M02AA06 |
| First authorisation | 12 January 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Traumalix forte EmGel, Gel | D | 12 January 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 40 | g | M02AA06 | 07.10.4. | D |
| 5 | 100 | g | M02AA06 | 07.10.4. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Traumalix forte EmGel authorised in Switzerland?
Yes. Traumalix forte EmGel is authorised by Swissmedic under authorisation number 66403, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Traumalix forte EmGel have?
Traumalix forte EmGel is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Traumalix forte EmGel?
The authorisation holder is Drossapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.